SIROLIMUS TABLETS
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2023-09-27
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 11
- Source
- full-release
- Hydrated at
- 2026-05-31 20:53:30
Label at a glance#
Label contents#
Full prescribing information#
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| SIROLIMUS Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e68235d1-1e8b-9d8c-fddb-764b8b692c25 | Product name | 7 | 20250331 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 9344cc31-0398-4e2f-a65e-a24a0de47fc4 | Product name | 1 | 20230103 |
| 741e13fe-61d8-4a4c-8c27-eb206b28f1bf | Product name | 1 | 20220613 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65841-771-01 | sirolimus | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 11 | |
| 65841-771-05 | sirolimus | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 11 | |
| 65841-771-06 | sirolimus | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 11 | |
| 65841-771-10 | sirolimus | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 11 | |
| 65841-771-16 | sirolimus | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 11 | |
| 65841-771-30 | sirolimus | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 11 | |
| 65841-771-77 | sirolimus | 10 in 1 CARTON | TABLET, FILM COATED | 10 | 11 | |
| 65841-772-01 | sirolimus | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 11 | |
| 65841-772-30 | sirolimus | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 11 | |
| 65841-772-77 | sirolimus | 10 in 1 CARTON | TABLET, FILM COATED | 10 | 11 | |
| 65841-773-01 | sirolimus | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 11 | |
| 65841-773-30 | sirolimus | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 11 | |
| 65841-773-77 | sirolimus | 10 in 1 CARTON | TABLET, FILM COATED | 10 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 65841-771 | SIROLIMUS TABLET, FILM COATED [ZYDUS LIFESCIENCES LIMITED] | 11 | Current NDC, Legacy NDC, 7 package rows | 20230928_82562b68-224d-482a-b399-a89b81d5eb31.zip |
| 65841-772 | SIROLIMUS TABLET, FILM COATED [ZYDUS LIFESCIENCES LIMITED] | 11 | Current NDC, 3 package rows | 20230928_82562b68-224d-482a-b399-a89b81d5eb31.zip |
| 65841-773 | SIROLIMUS TABLET, FILM COATED [ZYDUS LIFESCIENCES LIMITED] | 11 | Current NDC, 3 package rows | 20230928_82562b68-224d-482a-b399-a89b81d5eb31.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SIROLIMUS | ACTIVE INGREDIENT | W36ZG6FT64 | 2 | |
| SIROLIMUS | ACTIVE MOIETY | W36ZG6FT64 | 2 | |
| ALPHA-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | 2 | |
| FD&C YELLOW NO. 5 | INACTIVE INGREDIENT | I753WB2F1M | 2 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 2 | |
| GLYCERYL MONOOLEATE | INACTIVE INGREDIENT | 4PC054V79P | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 2 | |
| POLOXAMER 188 | INACTIVE INGREDIENT | LQA7B6G8JG | 2 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | 2 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | 2 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 2 |
Products#
Every source-derived product name is available through these pages.
- sirolimus
- ALPHA-TOCOPHEROL ACETATE
- CELLULOSE, MICROCRYSTALLINE
- CITRIC ACID MONOHYDRATE
- CROSPOVIDONE (15 MPA.S AT 5%)
- FD&C YELLOW NO. 5
- FERRIC OXIDE YELLOW
- GLYCERYL OLEATE
- HYPROMELLOSES
- LACTOSE MONOHYDRATE
- POLOXAMER 188
- POLYETHYLENE GLYCOL, UNSPECIFIED
- POVIDONE
- SUCROSE
- TALC
- TITANIUM DIOXIDE
- CROSPOVIDONE (120 .MU.M)
- HYPROMELLOSE 2910 (6 MPA.S)
- POLYETHYLENE GLYCOL 3350
- POLYETHYLENE GLYCOL 6000
- POVIDONE K30
- FERRIC OXIDE RED
- POLYETHYLENE GLYCOL 8000
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 65841-771 | 65841-771-01, 65841-771-06, 65841-771-16, 65841-771-05, 65841-771-10, 65841-771-30, 65841-771-77 |
| 65841-772 | 65841-772-01, 65841-772-30, 65841-772-77 |
| 65841-773 | 65841-773-01, 65841-773-30, 65841-773-77 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET, FILM COATED / ORAL | 1.68 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, FILM COATED / ORAL | 6 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED / ORAL | 968 mg | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | POWDER, FOR SUSPENSION / ORAL | NA | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, FILM COATED / ORAL | 6 mg | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | TABLET / ORAL | 3 mg | ||
| POLOXAMER 188 | POLOXAMER 188 | LQA7B6G8JG | TABLET, FILM COATED / ORAL | 3 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET, FILM COATED / ORAL | 1.68 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | POWDER, FOR SUSPENSION / ORAL | NA | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, FILM COATED / ORAL | 6 mg | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | TABLET / ORAL | 3 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| POLOXAMER 188 | POLOXAMER 188 | LQA7B6G8JG | TABLET, FILM COATED / ORAL | 3 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, FILM COATED / ORAL | 6 mg | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET, FILM COATED / ORAL | 1.68 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | CAPSULE / ORAL | NA | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, FILM COATED / ORAL | 6 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED / ORAL | 968 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED / ORAL | 968 mg | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | CAPSULE / ORAL | NA | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | CAPSULE / ORAL | NA | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | CAPSULE / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | TABLET / ORAL | 3 mg | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | POWDER, FOR SUSPENSION / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | TABLET / ORAL | 3 mg | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET, FILM COATED / ORAL | 1.68 mg | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | TABLET / ORAL | 3 mg | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | POWDER, FOR SUSPENSION / ORAL | NA | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | CAPSULE / ORAL | NA | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | POWDER, FOR SUSPENSION / ORAL | NA | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, FILM COATED / ORAL | 6 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| GLYCERYL MONOOLEATE | GLYCERYL OLEATE | 4PC054V79P | CAPSULE / ORAL | NA | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, FILM COATED / ORAL | 6 mg |
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A201676-001 | SIROLIMUS | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | |
| A201676-002 | SIROLIMUS | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | |
| A201676-003 | SIROLIMUS | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A201676-001 | AB |
| A201676-002 | AB |
| A201676-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A201676-002 | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A201676-003 | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A201676-002 | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A201676-003 | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201676-002 | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201676-003 | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201676-002 | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201676-003 | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201676-002 | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201676-003 | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201676-002 | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201676-003 | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201676-002 | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201676-003 | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201676-002 | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201676-003 | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201676-002 | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201676-003 | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201676-002 | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201676-003 | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201676-002 | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201676-003 | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201676-002 | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201676-003 | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A201676-002 | SIROLIMUS | 2MG | TABLET / ORAL | AB | 2023-02-15 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A201676-003 | SIROLIMUS | 0.5MG | TABLET / ORAL | AB | 2014-01-08 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A201676-001 | SIROLIMUS | 1MG | TABLET / ORAL | AB | 2023-02-15 | 79d66fd596c7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A201676-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A201676-002 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A201676-003 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A201676-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A201676-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A201676-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A201676-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201676-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201676-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A201676-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201676-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201676-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201676-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201676-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201676-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A201676-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A201676-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A201676-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201676-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201676-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201676-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201676-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201676-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201676-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201676-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201676-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201676-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201676-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201676-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201676-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201676-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201676-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201676-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201676-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201676-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201676-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A201676-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A201676-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A201676-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A201676-001 | AB | 1 | 79d66fd596c7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| sirolimus | SIROLIMUS | Zydus Lifesciences Limited | 82562b68-224d-482a-b399-a89b81d5eb31 | 2023-09-27 | 65841-771-30 65841-772-30 65841-773-77 65841-772-77 65841-772-01 65841-771-10 65841-771-05 65841-773-01 65841-773-30 65841-771-06 65841-771-01 65841-771-77 65841-771-16 65841-773 65841-771 65841-772 65841077301 65841077177 65841077106 65841077377 65841077105 65841077277 65841077110 65841077230 65841077201 65841077130 65841077116 65841077101 65841077330 7e6e294d-cf29-40e2-91e1-9693fdcd6b6c 82562b68-224d-482a-b399-a89b81d5eb31 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


